LDH community-based testing site closing in Acadiana
The Louisiana Department of Health's community-based testing site at Evangeline Downs Casino in Region 4 (Acadiana) will close permanently on Friday, January 28, 2022.
An official website of the State of Louisiana.
The Louisiana Department of Health's community-based testing site at Evangeline Downs Casino in Region 4 (Acadiana) will close permanently on Friday, January 28, 2022.
The five Northshore parish health units will offer testing and/or vaccinations during limited hours, 12 to 3 p.m., on Friday.
The Louisiana Department of Health's (LDH) community-based COVID-19 vaccine and testing sites in Region 2 (Baton Rouge area) will have a delayed opening on Friday, Jan. 21, due to the forecasted weather on that day.
The Louisiana Department of Health's (LDH) community-based COVID-19 testing sites in Region 4 (Acadiana) will have a delayed opening on Friday, Jan. 21 due to the forecasted weather, and the Ville Platte Civic Center testing site will be closed on that day.
Sites affected are Lutcher Senior Center and Houma Municipal Center.
Vaccine sites will operate during regular hours on Thursday and will close on Friday. Parish health units will continue to operate as normal on Friday.
The Louisiana Department of Health reported 29,125 new cases Tuesday since January 14, bringing the total number of confirmed cases to 1,025,748.
Louisiana WIC participants who would like to access virtual infant feeding support through Pacify can contact their local WIC clinic or call 1-800-251-2229. All WIC participants are eligible.
Local, state and federal partners will host a series of free community events designed to inform residents of health plan options available through the Federal Health Insurance Marketplace. The events will be held in Gretna, Baton Rouge, New Roads, Lafayette and Lake Charles starting today.
LDH has reviewed the latest CDC recommendations and alerted all vaccine providers in the state that this guidance is effective immediately.
Do not visit an emergency room simply to obtain a test if you have mild or no symptoms. Emergency rooms are for the seriously ill or people needing immediate medical attention.
The U.S. Food and Drug Administration recently issued an Emergency Use Authorization for Pfizer's Paxlovid (nirmatrelvir tablets and ritonavir tablets) - the first oral treatment for COVID-19.